Insiders / Astley-Sparke Philip
Astley-Sparke Philip
CIK 1376491personinsider
Companies
2
First seen
Feb 20, 2026
Last activity
Jun 17, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Replimune Group, Inc. · REPL | 1,412,414 | — |
| enGene Therapeutics Inc. · ENGN | — | — |
All securities held
3 positions · latest reported per filing
| Company | Security | Shares |
|---|---|---|
| enGene Therapeutics Inc. | Stock Option (Right to Buy)Derivative | 31,000 |
| Replimune Group, Inc. | Common Stock | 1,412,414 |
| Replimune Group, Inc. | Stock Option (right to buy)Derivative | 75,000 |
Activity
InsidersInstitutions
This person's insider trades (Form 4), across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| May 18, 2026 | Sell | REPL Replimune Group, Inc. Common Stock | $89.7K | -18K -1.23% | 1,412,414 1.68% of shares | low |
| Apr 1, 2026 | Grant | REPL Replimune Group, Inc. Common Stock | $0 | +50K +3.62% | 1,430,071 1.70% of shares | low |
| Feb 18, 2026 | Gift | REPL Replimune Group, Inc. Common Stock | $0 | -25K -1.78% | 1,380,071 1.64% of shares | low |
| Jun 16, 2026 | Grant | ENGN enGene Therapeutics Inc. Stock Option (Right to Buy) | — | +31K | 31,000 0.05% of shares | low |
| Apr 1, 2026 | Grant | REPL Replimune Group, Inc. Stock Option (right to buy) | — | +75K | 75,000 0.09% of shares | low |